Form 4: UnitedHealth Group Director Acquires Shares Through Dividend Equivalents
SEC Form 4 Filing
Frederick William McNabb III, a director at UnitedHealth Group, acquired 30 shares of common stock through dividend equivalents on vested deferred stock units.
Summary
- Frederick William McNabb III, a director of UnitedHealth Group, acquired 30 shares of common stock on December 17, 2024.
- The acquisition was a result of dividend equivalents paid on vested deferred stock units.
- These dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.
- Following the transaction, Mr. McNabb directly owns 13,253 shares of UnitedHealth Group stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction, which is generally positive as it shows director alignment with shareholder interests. There is no indication of any negative sentiment.
Positives
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the compensation structure for directors and executives.
Comparison to Industry Standards
- Many large publicly traded companies use stock-based compensation, including dividend equivalents, as part of their executive and director compensation packages.
- This type of transaction is common and is generally viewed as a standard practice in the industry.
- Companies like CVS Health, Cigna, and Anthem also use similar compensation methods for their directors and executives.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it shows director alignment with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Date of the transaction where 30 shares were acquired through dividend equivalents. |
| 12/19/2024 | Date the Form 4 was signed by the Attorney-in-Fact. |
Keywords
UnitedHealth Group, Director, Share Acquisition, Dividend Equivalents, Stock Units, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.